CLINICAL_TRIALS
trial_result
· 2012-03-05
Clinical Trial Update: Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer [Phase 1]
Summary
Open-label Phase 1 dose-finding trial of TRC105 in patients with solid cancers has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tracon Pharmaceuticals Inc. | Conditions: Cancer, Neoplasm Metastasis | Phase 1 | Status: COMPLETED